DE60133887D1 - Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber - Google Patents
Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleberInfo
- Publication number
- DE60133887D1 DE60133887D1 DE60133887T DE60133887T DE60133887D1 DE 60133887 D1 DE60133887 D1 DE 60133887D1 DE 60133887 T DE60133887 T DE 60133887T DE 60133887 T DE60133887 T DE 60133887T DE 60133887 D1 DE60133887 D1 DE 60133887D1
- Authority
- DE
- Germany
- Prior art keywords
- adenosine
- cirrhosis
- fatteners
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18154600P | 2000-02-10 | 2000-02-10 | |
PCT/US2001/004341 WO2001058241A2 (en) | 2000-02-10 | 2001-02-12 | Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60133887D1 true DE60133887D1 (de) | 2008-06-19 |
Family
ID=22664744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60133887T Expired - Lifetime DE60133887D1 (de) | 2000-02-10 | 2001-02-12 | Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber |
Country Status (11)
Country | Link |
---|---|
US (1) | US6555545B2 (de) |
EP (1) | EP1272897B1 (de) |
JP (1) | JP2004502640A (de) |
AT (1) | ATE394104T1 (de) |
AU (2) | AU3812401A (de) |
CA (1) | CA2398908C (de) |
DE (1) | DE60133887D1 (de) |
DK (1) | DK1272897T3 (de) |
ES (1) | ES2307593T3 (de) |
PT (1) | PT1272897E (de) |
WO (1) | WO2001058241A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6196459B1 (en) * | 1998-05-11 | 2001-03-06 | Ubiq Incorporated | Smart card personalization in a multistation environment |
WO2003080649A2 (en) * | 2002-03-20 | 2003-10-02 | Regents Of The University Of Minnesota | Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
ITRM20070088A1 (it) * | 2007-02-19 | 2008-08-20 | Francesco Fringuelli | Composti derivati della colchicina, procedimento per la loro preparazione e usi in campo medico. |
WO2009023179A2 (en) * | 2007-08-10 | 2009-02-19 | Genelabs Technologies, Inc. | Nitrogen containing bicyclic chemical entities for treating viral infections |
WO2009055021A1 (en) * | 2007-10-26 | 2009-04-30 | New York University School Of Medicine | Methods and compositions for treating hepatic diseases |
MX2010007426A (es) * | 2008-01-31 | 2010-08-18 | Astellas Pharma Inc | Composiciones farmaceuticas para tratar trastorno del higado graso. |
US8536306B2 (en) | 2008-10-01 | 2013-09-17 | The Scripps Research Institute | Human A2A adenosine receptor crystals and uses thereof |
US20100204265A1 (en) * | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
JP5765239B2 (ja) | 2009-03-13 | 2015-08-19 | アドヴィナス・セラピューティックス・リミテッド | 置換縮合ピリミジン化合物 |
JP5648044B2 (ja) * | 2009-03-20 | 2015-01-07 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニSigma−Tau Industrie Farmaceutiche Riunite Societa Per Azioni | アデノシンa2a受容体のリガンドとして有用なトリアゾリルプリンの酸化誘導体とその薬剤としての使用 |
WO2011055391A1 (en) | 2009-11-09 | 2011-05-12 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds, its preparation and uses thereof |
PL2531492T3 (pl) | 2010-02-05 | 2016-10-31 | Pochodne 1,2,4-triazyno-4-aminy | |
WO2012066330A1 (en) | 2010-11-17 | 2012-05-24 | Heptares Therapeutics Limited | Compounds useful as a2a receptor inhibitors |
US20200369665A1 (en) | 2017-06-30 | 2020-11-26 | Ryvu Therapeutics S.A. | Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor |
WO2019123482A1 (en) | 2017-12-19 | 2019-06-27 | Impetis Biosciences Ltd. | Pharmaceutical composition for the treatment of cancer |
ES2928238T3 (es) | 2018-01-04 | 2022-11-16 | Impetis Biosciences Ltd | Compuestos tricíclicos, composiciones y aplicaciones medicinales de los mismos |
WO2020128036A1 (en) | 2018-12-21 | 2020-06-25 | Ryvu Therapeutics S.A. | Modulators of the adenosine a2a receptor |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705658A (en) | 1986-04-07 | 1987-11-10 | Capsule Technology International, Ltd. | Method for drying gelatin in the manufacture of hard shell gelatin capsules |
US5063233A (en) | 1986-11-14 | 1991-11-05 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists |
US4968697A (en) | 1987-02-04 | 1990-11-06 | Ciba-Geigy Corporation | 2-substituted adenosine 5'-carboxamides as antihypertensive agents |
US5036381A (en) | 1990-06-15 | 1991-07-30 | Motorola, Inc. | Multiple electronic devices within a single carrier structure |
GB2264948B (en) | 1992-03-13 | 1996-10-16 | Merck & Co Inc | Human adenosine receptors |
US5426101A (en) | 1992-09-30 | 1995-06-20 | Merrell Dow Pharmaceuticals Inc. | 2-substituted adenosines with A-2 receptor affinity |
WO1994023723A1 (en) | 1993-04-15 | 1994-10-27 | New York University | Adenosine receptor agonists for the promotion of wound healing |
US5877180A (en) * | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
US5859019A (en) | 1997-03-07 | 1999-01-12 | Trustees Of The University Of Pennsylvania | Methods for protecting against cardiac ischemia by administering adenosine A2a receptor antagonists |
CA2289731A1 (en) | 1997-05-09 | 1998-11-12 | The United States Of America, Represented By The Secretary, Department O F Health And Human Services | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
WO1998052611A1 (fr) * | 1997-05-23 | 1998-11-26 | Nippon Shinyaku Co., Ltd. | Preparation medicamenteuse aux fins de la prevention et du traitement des hepatopathies |
US5916910A (en) | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
US6303619B1 (en) * | 1998-03-12 | 2001-10-16 | University Of Virginia | Meta-substituted acidic 8-phenylxanthine antagonists of A3 human adenosine receptors |
US6232297B1 (en) * | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
-
2001
- 2001-02-12 AT AT01910529T patent/ATE394104T1/de not_active IP Right Cessation
- 2001-02-12 WO PCT/US2001/004341 patent/WO2001058241A2/en active Application Filing
- 2001-02-12 DE DE60133887T patent/DE60133887D1/de not_active Expired - Lifetime
- 2001-02-12 ES ES01910529T patent/ES2307593T3/es not_active Expired - Lifetime
- 2001-02-12 CA CA002398908A patent/CA2398908C/en not_active Expired - Fee Related
- 2001-02-12 PT PT01910529T patent/PT1272897E/pt unknown
- 2001-02-12 AU AU3812401A patent/AU3812401A/xx active Pending
- 2001-02-12 JP JP2001557366A patent/JP2004502640A/ja active Pending
- 2001-02-12 US US09/780,365 patent/US6555545B2/en not_active Expired - Lifetime
- 2001-02-12 AU AU2001238124A patent/AU2001238124B2/en not_active Ceased
- 2001-02-12 DK DK01910529T patent/DK1272897T3/da active
- 2001-02-12 EP EP01910529A patent/EP1272897B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2398908C (en) | 2009-12-15 |
US6555545B2 (en) | 2003-04-29 |
AU3812401A (en) | 2001-08-20 |
AU2001238124B2 (en) | 2006-05-25 |
PT1272897E (pt) | 2008-08-18 |
US20020002145A1 (en) | 2002-01-03 |
ATE394104T1 (de) | 2008-05-15 |
WO2001058241A9 (en) | 2002-10-17 |
CA2398908A1 (en) | 2001-08-16 |
JP2004502640A (ja) | 2004-01-29 |
EP1272897A2 (de) | 2003-01-08 |
DK1272897T3 (da) | 2008-09-15 |
EP1272897B1 (de) | 2008-05-07 |
ES2307593T3 (es) | 2008-12-01 |
WO2001058241A2 (en) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE394104T1 (de) | Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber | |
DE602004028841D1 (de) | Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c | |
ATE293989T1 (de) | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten | |
MXPA02012443A (es) | Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos. | |
WO2005027895A3 (en) | Thyroid hormone analogs and methods of use in angiogenesis | |
DZ2618A1 (fr) | Emploi des antagonistes des récepteurs de 5-HT3 dans le traitement de la colopathie. | |
ATE334985T1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
SG155054A1 (en) | Human anti- neutralizing antibodies as selective pathway inhibitors | |
ATE210449T1 (de) | Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards | |
ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
ATE364595T1 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
WO2008043107A3 (en) | Use of tight junction antagonists to treat inflammatory bowel disease | |
ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
DE60144514D1 (de) | Verwendung von il-18 inhibitoren | |
JP2004502640A5 (de) | ||
ATE344670T1 (de) | Synergistische kombination zur behandlung von kolorektalkarzinom | |
DK1001775T3 (da) | Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion | |
DE69925578D1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
EA200700979A1 (ru) | Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола | |
TNSN03065A1 (en) | BIOPESTICIDE COMPOSITIONS | |
WO2002015664A3 (en) | Methods of preventing or treating west nile virus and other infections | |
IS4847A (is) | Aðferð til meðferðar gegn hjartabilun þar sem notuð eru mótlyf gegn endóþelíni | |
ATE348628T1 (de) | Behandlung von hepatitis c mit thymosin, interferon und ribavirin | |
ATE332704T1 (de) | Behandlung von hepatitis c mit thymosin und pegyliertem interferon | |
PT1313500E (pt) | Associacoes de dalfopristina/quinupristina com o cefpirome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |